May-Thurner Syndrome Diagnosis: A Comprehensive Guide for Automotive Repair Experts and Healthcare Professionals

May-Thurner Syndrome (MTS), also known as iliac vein compression syndrome, is a vascular condition often characterized by the compression of the left common iliac vein by the overlying right common iliac artery. This anatomical anomaly can lead to venous insufficiency, obstruction, and an increased risk of deep vein thrombosis (DVT) in the affected limb. While initially described in cadaveric studies, May-Thurner Syndrome is increasingly recognized as a clinically significant entity with implications for both diagnosis and treatment. For experts in automotive repair, understanding complex systems and diagnostic processes is key; similarly, in the medical field, accurate and timely May Thurner Diagnosis is crucial for effective patient management and preventing serious complications.

This article aims to provide an in-depth exploration of May-Thurner Syndrome, with a particular focus on may thurner diagnosis. It will delve into the etiology, epidemiology, pathophysiology, clinical presentation, and various diagnostic modalities available for this condition. Furthermore, it will outline the current treatment strategies and highlight the importance of an interprofessional approach to improve patient outcomes. This comprehensive guide is designed to enhance the knowledge base of healthcare professionals and those with a keen interest in intricate diagnostic challenges, such as experienced automotive repair experts who appreciate detailed system analysis.

Understanding May-Thurner Syndrome: Etiology and Mechanisms

The primary cause of May-Thurner Syndrome is the anatomical compression of a common iliac vein, most frequently the left, against the lumbar spine by the overlying contralateral common iliac artery. This compression is often located between the aortic origination of the common iliac artery and the iliofemoral junction. The constant pulsations from the artery exert pressure on the vein, leading to endothelial injury. This repeated trauma to the venous endothelium triggers a cascade of events, including the formation of intraluminal fibrous bands or spurs within the vein.

Over time, these fibrous bands can cause significant stenosis or narrowing of the iliac vein, impeding normal venous return from the lower extremity. This obstruction contributes to venous hypertension and increases the predisposition to thrombus formation. While the left iliofemoral vein is the most commonly affected site in May-Thurner Syndrome, variations involving the right common iliac vein or even the inferior vena cava have been documented, demonstrating the spectrum of anatomical presentations.

Epidemiology and Risk Factors in May-Thurner Syndrome

The precise epidemiology of May-Thurner Syndrome remains somewhat elusive due to its underdiagnosed nature. Many individuals with the anatomical compression may remain asymptomatic, and the syndrome often comes to clinical attention only when complications such as DVT arise. It is estimated that May-Thurner Syndrome may account for 2% to 5% of all cases of deep vein thrombosis. However, radiological studies in patients with left lower extremity DVT have reported a prevalence of May-Thurner Syndrome ranging from 22% to 76%, suggesting it is a more significant contributor to iliofemoral DVT than previously recognized.

Studies indicate a higher incidence of symptomatic May-Thurner Syndrome in women, approximately twice that of men. Women typically present between 30 and 50 years of age. Certain conditions and life events can increase the risk of symptomatic May-Thurner Syndrome, including:

Stasis: Prolonged periods of immobility, such as long flights or bed rest.
Surgery: Postoperative states, particularly orthopedic or pelvic surgeries.
Pregnancy and Postpartum Period: Hormonal changes and increased venous pressure during pregnancy and after childbirth.
Oral Contraceptive Use: Estrogen-containing contraceptives can increase the risk of hypercoagulability.
Hypercoagulable States: Inherited or acquired thrombophilias.

Understanding these risk factors is essential for identifying individuals who may be at higher risk for developing symptomatic May-Thurner Syndrome and who may benefit from heightened clinical suspicion and appropriate may thurner diagnosis strategies.

Pathophysiology: From Compression to Thrombosis

The pathophysiology of May-Thurner Syndrome is a progressive process initiated by chronic venous compression. The pulsatile nature of the overlying artery causes repetitive trauma to the iliac vein endothelium. In response to this injury, the vein undergoes histological changes, primarily the deposition of collagen and elastin, leading to the formation of fibrous bands or spurs within the vein lumen.

These spurs, categorized histologically as central, lateral, or fenestrated, contribute to venous stenosis and obstruction. While collateral venous pathways can develop to partially compensate for the impaired venous outflow, these may not always be sufficient, particularly under conditions of increased venous stasis or hypercoagulability.

When additional risk factors for thrombosis are present, such as stasis, endothelial injury from other causes, or a prothrombotic state, the already compromised venous flow in May-Thurner Syndrome significantly increases the risk of DVT. The thrombus often forms in the iliofemoral vein and can propagate distally into the femoral and popliteal veins, resulting in extensive thrombotic burden. Furthermore, pulmonary embolism, a potentially life-threatening complication, can occur when the thrombus dislodges and travels to the lungs.

Clinical Presentation: Recognizing the Signs and Symptoms

The clinical presentation of May-Thurner Syndrome is highly variable, ranging from asymptomatic anatomical findings to acute, symptomatic DVT. Some patients experience a gradual onset of venous insufficiency symptoms, while others present with sudden, dramatic symptoms of DVT.

Common signs and symptoms associated with May-Thurner Syndrome include:

Lower Extremity Swelling (Edema): Often unilateral, affecting the left leg more frequently. Swelling may be mild and intermittent initially, worsening with prolonged standing or activity and improving with rest and elevation.
Pain and Heaviness: Leg pain, aching, or a feeling of heaviness in the affected limb.
Skin Changes: Chronic venous insufficiency can lead to skin hyperpigmentation, telangiectasias (spider veins), and venous ulcers in advanced cases.
Venous Claudication: Leg pain induced by exercise and relieved by rest, resulting from venous outflow obstruction.
Acute DVT: Sudden onset of significant leg pain, swelling, warmth, and redness, often in the left leg. In some cases, phlegmasia cerulea dolens, a severe, limb-threatening form of DVT, can occur.

It is crucial to note that subtle symptoms, such as mild left leg tightness resolving with sleep, minor swelling, or early skin changes, may be easily overlooked or misattributed to other causes. A high index of suspicion is necessary for timely may thurner diagnosis, especially in younger women presenting with unexplained left lower extremity symptoms or DVT.

The progression of May-Thurner Syndrome can be conceptualized in three stages:

Stage I: Asymptomatic iliac vein compression.
Stage II: Formation of venous spurs and development of mild symptoms of venous insufficiency.
Stage III: Development of DVT in the affected lower extremity.

May-Thurner Diagnosis: A Multi-Modal Approach

Accurate may thurner diagnosis relies on a combination of clinical suspicion, physical examination, and appropriate imaging modalities. The diagnostic process aims to confirm iliac vein compression, assess for the presence of venous spurs, and identify any thrombus formation.

Initial Evaluation: Doppler Ultrasonography

Doppler ultrasonography is typically the first-line imaging modality for evaluating suspected May-Thurner Syndrome. It is non-invasive, readily available, and can assess venous flow, reflux, and vessel diameter. Doppler ultrasound can detect distal thrombus and may suggest proximal venous obstruction. However, its sensitivity in directly visualizing iliac vein compression and spurs can be limited due to technical factors such as body habitus and bowel gas. If distal DVT is excluded but proximal obstruction is suspected, further imaging is warranted.

Advanced Imaging Techniques for May-Thurner Diagnosis

When Doppler ultrasound is inconclusive or suboptimal for assessing proximal veins, more advanced imaging modalities are essential for definitive may thurner diagnosis. These include:

Computed Tomography (CT) Venography: CT venography offers excellent sensitivity and specificity (greater than 95%) for detecting iliac vein compression, stenosis, collaterals, and DVT. It provides a comprehensive anatomical view, allowing for the exclusion of other causes of iliac vein compression, such as lymphadenopathy, malignancy, or hematoma. However, CT venography involves ionizing radiation and contrast agents, and may overestimate venous compression in dehydrated patients.
Magnetic Resonance (MR) Venography: MR venography is comparable to CT venography in diagnostic accuracy and offers the advantage of no ionizing radiation. It provides superior soft tissue detail and is safe for use in pregnancy. However, MR venography can also be influenced by patient hydration status and may be less readily available and more expensive than CT venography. Furthermore, isolated MR venography might be insufficient as iliac vein compression can be intermittent.
Intravascular Ultrasonography (IVUS): IVUS is considered the gold standard for may thurner diagnosis and pre-intervention assessment. This invasive technique involves inserting a small ultrasound catheter directly into the iliac vein. IVUS provides highly detailed, real-time images of the venous lumen, allowing for precise evaluation of vein compression, stenosis severity, fibrous spurs, and thrombus characteristics. IVUS has a sensitivity exceeding 98% for iliac vein compression and is invaluable for guiding stent placement and assessing treatment outcomes. While invasive, IVUS avoids contrast agents and radiation and provides crucial information for treatment planning, particularly in complex cases.

Differential Diagnosis

In the process of may thurner diagnosis, it is important to consider other conditions that can mimic or contribute to iliac vein compression and lower extremity venous symptoms. The differential diagnosis includes:

Secondary Iliac Vein Compression: Compression due to extrinsic masses such as malignancy, lymphadenopathy, hematoma, uterine leiomyoma, aortoiliac aneurysm, retroperitoneal fibrosis, or osteophytes.
Thrombophilia: Inherited or acquired hypercoagulable states predisposing to DVT.
Other Causes of Venous Insufficiency: Primary valvular insufficiency, chronic venous obstruction from previous DVT (postthrombotic syndrome).
Cellulitis and Lymphedema: To be considered in cases presenting with leg swelling and pain, but these typically lack the specific venous findings of May-Thurner Syndrome.

Treatment and Management Strategies

Treatment for May-Thurner Syndrome is tailored to the patient’s clinical presentation and the presence or absence of thrombus. The primary goals of treatment are to relieve venous obstruction, restore venous flow, alleviate symptoms, and prevent long-term complications such as postthrombotic syndrome.

Non-Thrombotic May-Thurner Syndrome

For patients with non-thrombotic May-Thurner Syndrome, particularly those with minimal symptoms, conservative management may be appropriate. This includes:

Compression Therapy: Graduated compression stockings to reduce venous hypertension and swelling.
Leg Elevation: To promote venous return.
Lifestyle Modifications: Avoiding prolonged standing or sitting, regular exercise.
Counseling on Prothrombotic Risks: Educating patients about risk factors for DVT and the importance of avoiding them.
Close Clinical Follow-up: Regular monitoring for symptom progression or development of thrombosis.

For patients with more pronounced symptoms of venous insufficiency in the absence of acute thrombosis, endovascular interventions are often considered.

Thrombotic May-Thurner Syndrome (Acute Iliofemoral DVT)

In patients presenting with acute iliofemoral DVT secondary to May-Thurner Syndrome, prompt and aggressive treatment is necessary to prevent pulmonary embolism and minimize the risk of postthrombotic syndrome. Treatment strategies include:

Anticoagulation: Immediate initiation of anticoagulation with heparin, followed by low-molecular-weight heparin or fondaparinux as a bridge to warfarin or novel oral anticoagulants (NOACs) like rivaroxaban. Anticoagulation alone, however, is insufficient to address the underlying venous compression in May-Thurner Syndrome.
Catheter-Directed Thrombolysis (CDT): CDT involves the local delivery of thrombolytic agents directly into the thrombus via a catheter. This technique, often combined with mechanical thrombectomy, aims to rapidly dissolve the thrombus and restore venous patency. Studies have demonstrated that CDT plus anticoagulation is superior to anticoagulation alone in reducing postthrombotic syndrome.
Venous Stenting: Following thrombus removal (either through CDT or pharmacomechanical thrombectomy), venous stenting is a crucial step in treating May-Thurner Syndrome. Stenting addresses the underlying iliac vein compression and prevents recurrent stenosis. Self-expanding venous stents are typically deployed across the compressed segment to maintain venous patency. Angioplasty alone without stenting is generally insufficient in May-Thurner Syndrome due to the irreversible nature of the venous stenosis.
Open Thrombectomy: In rare cases where thrombolysis is contraindicated, open surgical thrombectomy followed by angioplasty and stenting may be considered. Surgical resection of the venous segment is rarely performed and is reserved for cases where endovascular approaches fail.

Post-Treatment Management and Prognosis

Following treatment for May-Thurner Syndrome, long-term management is essential. This includes:

Continued Anticoagulation: Duration of anticoagulation depends on individual risk factors and the presence of residual thrombus or persistent hypercoagulability.
Compression Therapy: Long-term use of compression stockings to minimize postthrombotic syndrome risk.
Regular Follow-up: Periodic clinical andDuplex ultrasound evaluations to monitor stent patency, assess for symptom recurrence, and manage any complications.

The prognosis for patients with May-Thurner Syndrome, when diagnosed and treated appropriately, is generally good. Timely intervention, particularly endovascular stenting, can significantly improve venous outflow, alleviate symptoms, and reduce the risk of long-term complications. Postthrombotic syndrome remains a potential complication, but its incidence can be substantially reduced with comprehensive treatment strategies, including thrombus removal and venous stenting.

The Interprofessional Team in May-Thurner Syndrome Management

Optimal management of May-Thurner Syndrome requires a collaborative, interprofessional team approach. Key healthcare professionals involved in the care of these patients include:

Interventional Radiologists: Crucial for performing diagnostic venography, IVUS, catheter-directed thrombolysis, and venous stenting.
Vascular Surgeons: Involved in surgical thrombectomy, open venous reconstruction (rarely), and overall management decisions.
Hematologists: Consulted for managing anticoagulation and evaluating for underlying thrombophilia.
Wound Care Specialists: To manage venous ulcers associated with chronic venous insufficiency.
Primary Care Practitioners and Emergency Department Providers: Essential for initial recognition of May-Thurner Syndrome and referral for specialized care.
Nurses and Physician Assistants: Play a vital role in patient education, pre- and post-procedural care, and ongoing management.
Pharmacists: To ensure appropriate anticoagulation management and medication reconciliation.
Physical Therapists: To guide patients in exercise regimens and rehabilitation.

Effective communication and coordination among these team members are paramount for ensuring timely may thurner diagnosis, appropriate treatment selection, and comprehensive patient care, ultimately leading to improved outcomes and quality of life for individuals with May-Thurner Syndrome.

Conclusion

May-Thurner Syndrome is a clinically significant vascular condition that requires a high index of suspicion for accurate may thurner diagnosis. Understanding the etiology, pathophysiology, and diverse clinical presentations of MTS is crucial for healthcare professionals. Advancements in imaging modalities, particularly IVUS, have significantly enhanced diagnostic accuracy. Endovascular interventions, including catheter-directed thrombolysis and venous stenting, have revolutionized the treatment of thrombotic May-Thurner Syndrome, offering improved outcomes and reduced long-term morbidity. By adopting a collaborative, interprofessional approach and focusing on early and accurate may thurner diagnosis, healthcare teams can effectively manage May-Thurner Syndrome and improve the lives of affected individuals. Just as expert automotive technicians meticulously diagnose complex vehicle issues, a similarly detailed and systematic approach is essential for tackling the diagnostic and therapeutic challenges posed by May-Thurner Syndrome.

References

1.Harbin MM, Lutsey PL. May-Thurner syndrome: History of understanding and need for defining population prevalence. J Thromb Haemost. 2020 Mar;18(3):534-542.
2.Poyyamoli S, Mehta P, Cherian M, Anand RR, Patil SB, Kalva S, Salazar G. May-Thurner syndrome. Cardiovasc Diagn Ther. 2021 Oct;11(5):1104-1111.
3.Burke RM, Rayan SS, Kasirajan K, Chaikof EL, Milner R. Unusual case of right-sided May-Thurner syndrome and review of its management. Vascular. 2006 Jan-Feb;14(1):47-50.
4.Abboud G, Midulla M, Lions C, El Ngheoui Z, Gengler L, Martinelli T, Beregi JP. “Right-sided” May-Thurner syndrome. Cardiovasc Intervent Radiol. 2010 Oct;33(5):1056-9.
5.Negus D, Fletcher EW, Cockett FB, Thomas ML. Compression and band formation at the mouth of the left common iliac vein. Br J Surg. 1968 May;55(5):369-74.
6.Cockett FB, Thomas ML. The iliac compression syndrome. Br J Surg. 1965 Oct;52(10):816-21.
7.Kaltenmeier CT, Erben Y, Indes J, Lee A, Dardik A, Sarac T, Ochoa Chaar CI. Systematic review of May-Thurner syndrome with emphasis on gender differences. J Vasc Surg Venous Lymphat Disord. 2018 May;6(3):399-407.e4.
8.Warad DM, Rao AN, Bjarnason H, Rodriguez V. Clinical Outcomes of May-Thurner Syndrome in Pediatric Patients: A Single Institutional Experience. TH Open. 2020 Jul;4(3):e189-e196.
9.Brinegar KN, Sheth RA, Khademhosseini A, Bautista J, Oklu R. Iliac vein compression syndrome: Clinical, imaging and pathologic findings. World J Radiol. 2015 Nov 28;7(11):375-81.
10.Ibrahim W, Al Safran Z, Hasan H, Zeid WA. Endovascular management of may-thurner syndrome. Ann Vasc Dis. 2012;5(2):217-21.
11.Knuttinen MG, Naidu S, Oklu R, Kriegshauser S, Eversman W, Rotellini L, Thorpe PE. May-Thurner: diagnosis and endovascular management. Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S159-S164.
12.Metzger PB, Rossi FH, Kambara AM, Izukawa NM, Saleh MH, Pinto IM, Amorim JE, Thorpe PE. Criteria for detecting significant chronic iliac venous obstructions with duplex ultrasound. J Vasc Surg Venous Lymphat Disord. 2016 Jan;4(1):18-27.
13.Wu WL, Tzeng WS, Wu RH, Tsai WL, Chen MC, Lin PC, Tsai IC. Comprehensive MDCT evaluation of patients with suspected May-Thurner syndrome. AJR Am J Roentgenol. 2012 Nov;199(5):W638-45.
14.McDermott S, Oliveira G, Ergül E, Brazeau N, Wicky S, Oklu R. May-Thurner syndrome: can it be diagnosed by a single MR venography study? Diagn Interv Radiol. 2013 Jan-Feb;19(1):44-8.
15.Radaideh Q, Patel NM, Shammas NW. Iliac vein compression: epidemiology, diagnosis and treatment. Vasc Health Risk Manag. 2019;15:115-122.
16.Forauer AR, Gemmete JJ, Dasika NL, Cho KJ, Williams DM. Intravascular ultrasound in the diagnosis and treatment of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol. 2002 May;13(5):523-7.
17.Speranza G, Sadek M, Jacobowitz G. Common iliac vein stenting for May-Thurner syndrome and subsequent pregnancy. J Vasc Surg Venous Lymphat Disord. 2022 Mar;10(2):348-352.
18.Seely KD, Arreola HJ, Paul LK, Higgs JA, Brooks B, Anderson RC. Seizures, deep vein thrombosis, and pulmonary emboli in a severe case of May-Thurner syndrome: a case report. J Med Case Rep. 2022 Nov 11;16(1):411.
19.Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Lohr JM, McLafferty RB, Murad MH, Padberg F, Pappas P, Raffetto JD, Wakefield TW., Society for Vascular Surgery. American Venous Forum. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2012 May;55(5):1449-62.
20.Koitabashi N, Niwamae N, Taguchi T, Ohyama Y, Takama N, Kurabayashi M. Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment. Thromb J. 2015;13:13.
21.Nakashima N, Sueta D, Kanemaru Y, Takashio S, Yamamoto E, Hanatani S, Kanazawa H, Izumiya Y, Kojima S, Kaikita K, Hokimoto S, Tsujita K. Successful treatment of deep vein thrombosis caused by iliac vein compression syndrome with a single-dose direct oral anti-coagulant. Thromb J. 2017;15:4.
22.Kang JM, Park KH, Ahn S, Cho S, Han A, Lee T, Jung IM, Kim JY, Min SK. Rivaroxaban after Thrombolysis in Acute Iliofemoral Venous Thrombosis: A Randomized, Open-labeled, Multicenter Trial. Sci Rep. 2019 Dec 30;9(1):20356.
23.Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM., CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012 Jan 07;379(9810):31-8.
24.Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, Jaff MR, Razavi MK, Kindzelski AL, Bashir R, Patel P, Sharafuddin M, Sichlau MJ, Saad WE, Assi Z, Hofmann LV, Kennedy M, Vedantham S., ATTRACT Trial Investigators. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation. 2019 Feb 26;139(9):1162-1173.
25.Berger A, Jaffe JW, York TN. Iliac compression syndrome treated with stent placement. J Vasc Surg. 1995 Mar;21(3):510-4.
26.Park JY, Ahn JH, Jeon YS, Cho SG, Kim JY, Hong KC. Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May-Thurner syndrome. Phlebology. 2014 Aug;29(7):461-70.
27.Nazarian GK, Bjarnason H, Dietz CA, Bernadas CA, Hunter DW. Iliofemoral venous stenoses: effectiveness of treatment with metallic endovascular stents. Radiology. 1996 Jul;200(1):193-9.
28.Montes MC, Carbonell JP, Gómez-Mesa JE. Endovascular and medical therapy of May-Thurner syndrome: Case series and scoping literature review. J Med Vasc. 2021 Apr;46(2):80-89.
29.Vedantham S, Millward SF, Cardella JF, Hofmann LV, Razavi MK, Grassi CJ, Sacks D, Kinney TB., Society of Interventional Radiology. Society of Interventional Radiology position statement: treatment of acute iliofemoral deep vein thrombosis with use of adjunctive catheter-directed intrathrombus thrombolysis. J Vasc Interv Radiol. 2006 Apr;17(4):613-6.
30.Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007 Nov;46(5):979-990.
31.Waheed KB, Mohammed HR, Salem KS, Shaltout MA, Alshehri AS, Said EF, Almubarak AS, Arulanantham ZJ. Left lower limb deep venous thrombosis, May-Thurner syndrome and endovascular management. Saudi Med J. 2022 Jan;43(1):108-112.
32.Igneri LA, Hammer JM. Systemic Thrombolytic Therapy for Massive and Submassive Pulmonary Embolism. J Pharm Pract. 2020 Feb;33(1):74-89.
33.Daley MJ, Murthy MS, Peterson EJ. Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem. Ther Adv Drug Saf. 2015 Apr;6(2):57-66.
34.Mousa AY, AbuRahma AF. May-Thurner syndrome: update and review. Ann Vasc Surg. 2013 Oct;27(7):984-95.
35.Choy KT, Bhutia S. Recurrent unilateral cellulitis: is it May-Thurner syndrome (MTS)? BMJ Case Rep. 2019 Jul 04;12(7)
36.Danish A, Mohammed AS, Kanagala SG, Aized M, Khan AA. An Unusual Case of May-Thurner Syndrome in a Middle-Aged IV Drug Abuser. Cureus. 2022 Sep;14(9):e29360.
37.Ono R, Takahashi H, Hori Y, Fukushima K. May-Thurner Syndrome with Calcified Uterine Leiomyoma. Intern Med. 2021 Jul 15;60(14):2343-2344.
38.Yi JA, Hadley JB, Kuwayama DP. Atypical May-Thurner syndrome caused by endovascular aortic aneurysm repair. J Vasc Surg Cases Innov Tech. 2020 Sep;6(3):397-400.
39.Liddell RP, Evans NS. May-Thurner syndrome. Vasc Med. 2018 Oct;23(5):493-496.
40.Comerota AJ, Grewal N, Martinez JT, Chen JT, Disalle R, Andrews L, Sepanski D, Assi Z. Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. J Vasc Surg. 2012 Mar;55(3):768-73.
41.Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997 Jul-Aug;82(4):423-8.
42.Casey ET, Murad MH, Zumaeta-Garcia M, Elamin MB, Shi Q, Erwin PJ, Montori VM, Gloviczki P, Meissner M. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg. 2012 May;55(5):1463-73.
43.Jones WS, Vemulapalli S, Parikh KS, Coeytaux RR, Crowley MJ, Raitz G, Johnston AL, Hasselblad V, McBroom AJ, Lallinger KR, Sanders-Schmidler GD. Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD) [Internet]. Agency for Healthcare Research and Quality (US); Rockville (MD): Apr 06, 2017.